Richard Boismenu

Richard Boismenu is Chief Scientific Officer at IgGenix. Dr. Boismenu brings over 20 years of research, drug development, strategic expertise, and executive leadership skills to IgGenix. He joins IgGenix from Coherus Biosciences, where he served as Vice President and Head of Product Development, and Chair of the Portfolio Strategy Committee overseeing all development programs. Prior to Coherus Biosciences, he worked for Genentech as Project Team Leader in the Portfolio Management and Operations Group where he led a number of immunology, ophthalmology and metabolic disorder development programs. Before Genentech, Dr. Boismenu was Senior Director at Repligen, where he led the Immunology and Cell Biology Group and oversaw external research collaborations. Earlier in his career, Dr. Boismenu was Assistant Professor of Immunology at The Scripps Research Institute, where he also completed a post-doctoral fellowship in the laboratory of Dr. Wendy Havran. He received his Ph.D. from McGill University and his B.Sc. from the Université de Montréal.

Richard Boismenu is the Chief Scientific Officer at IgGenix, based in United States, North America. With a background in Biotechnology, Richard Boismenu has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.